Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

23,105 total articles

Nike Shares Slide After Cautious FY2027 Outlook and China Weakness

Nike Shares Slide After Cautious FY2027 Outlook and China Weakness

Nike shares dropped sharply in pre-market trade after management issued a cautious revenue outlook for fiscal 2027 despite a fourth-quarter beat. A one-time tariff benefit inflated headline earnings, Greater China sales plunged further, and the departure of longtime CFO added to investor concern, leaving the stock trading below $40 and near its 52-…

Oryzon Shares Slide After Accelerated Placement to Raise Up to €10 Million

Oryzon Shares Slide After Accelerated Placement to Raise Up to €10 Million

Oryzon Genomics' stock dropped 11% after the company initiated an accelerated private placement to raise up to €10 million, with an option to increase to €15 million depending on demand. The placement, conducted within the European Economic Area with pre-emptive subscription rights excluded, aims to bolster the balance sheet and speed development o…

JD Sports Slips After Nike Signals Continued Revenue Weakness

JD Sports Slips After Nike Signals Continued Revenue Weakness

Shares of UK retailer JD Sports edged lower after Nike reported a modest revenue decline in its fiscal fourth quarter and cautioned that revenue will likely fall further into the first half of fiscal 2027. Nike cited stiff competition, elevated inventory and a sharp sales contraction in Greater China, while North America showed modest recovery. The…

CMC Markets Shares Jump After Large FY2027 Profit Upgrade

CMC Markets Shares Jump After Large FY2027 Profit Upgrade

CMC Markets stock climbed sharply after management raised its FY2027 net operating income target to at least 350 million and introduced an EBITDA target of 250 million, materially ahead of the guidance issued weeks earlier. Strong FY2026 results and expanding institutional partnerships were cited as the basis for the upgraded outlook, prompting a…

AlzeCure Shares Jump After Major Licensing Deal with QuantumCell

AlzeCure Shares Jump After Major Licensing Deal with QuantumCell

AlzeCure Pharma's stock leapt following a licensing and collaboration agreement granting Denmark-based QuantumCell ApS global rights to the NeuroRestore platform and lead Alzheimer’s candidate ACD856. The transaction was reported to be worth in excess of $2.2 billion and comes shortly after a separate out-licensing deal with Eli Lilly for the Alzst…

Renault Shares Lifted After Management Reaffirms 2026 Targets

Renault Shares Lifted After Management Reaffirms 2026 Targets

Renault shares climbed roughly 2.0% to trade at €25.57 after the automaker held a pre-close investor call on June 30, 2026. Management confirmed full-year 2026 targets for operating margin and industrial free cash flow, a move that reduced near-term uncertainty and attracted buyers as the stock traded close to its 52-week low. Positive macro data o…

Ipsen to Acquire Memo Therapeutics in Deal That Could Top €700 Million

Ipsen to Acquire Memo Therapeutics in Deal That Could Top €700 Million

Ipsen has entered an agreement to acquire Swiss biotech Memo Therapeutics in a transaction valued at up to 700 million euros, centered on Memo's experimental drug potravitug for BK polyomavirus-associated nephropathy. Ipsen will pay 200 million euros upfront and the balance through development, regulatory and sales milestones; Memo's unrelated asse…

Aker Shares Jump After $3.1 Billion Sale of Cognite to Schneider Electric

Aker Shares Jump After $3.1 Billion Sale of Cognite to Schneider Electric

Aker's stock climbed sharply after the Norwegian conglomerate agreed to sell its entire holding in Cognite Holding B.V. to Schneider Electric for $3.1 billion in cash. The transaction produces roughly $1.48 billion in proceeds for Aker, generates an uplift to reported net asset value and leads the company to reinvest the windfall into a larger stak…

Bending Spoons Prices Nasdaq IPO at $29 a Share

Bending Spoons Prices Nasdaq IPO at $29 a Share

Bending Spoons S.p.A. set its initial public offering price at $29.00 per share, above the previously indicated $26 to $28 range. The deal comprises 57,971,015 ordinary shares, with the company selling 34,398,640 shares and certain selling shareholders offering 23,572,375 shares. Shares are expected to start trading on the Nasdaq Global Select Mark…